These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19436214)

  • 1. A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R; Hildenbrand R
    Eur J Cancer Prev; 2009 Aug; 18(4):307-15. PubMed ID: 19436214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
    Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
    Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer.
    Wheeler CM; Hunt WC; Schiffman M; Castle PE;
    J Infect Dis; 2006 Nov; 194(9):1291-9. PubMed ID: 17041856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, evolution, and features of infection with human papillomavirus: a 15-year longitudinal study of routine screening of a women population in the north of Spain.
    de Oña M; Alvarez-Argüelles ME; Torrents M; Villa L; Rodriguez-Feijoo A; Palacio A; Boga JA; Tamargo A; Melón S
    J Med Virol; 2010 Apr; 82(4):597-604. PubMed ID: 20166173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women.
    Nielsen A; Kjaer SK; Munk C; Osler M; Iftner T
    J Med Virol; 2010 Apr; 82(4):616-23. PubMed ID: 20166190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
    Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
    J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.
    Louvanto K; Rintala MA; Syrjänen KJ; Grénman SE; Syrjänen SM
    J Infect Dis; 2010 Aug; 202(3):436-44. PubMed ID: 20557239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the prevalence of human papillomavirus infection and distribution of types in Shenyang city].
    Zhang X; Wang CY; Shi JF; Gao Y; Li LK
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):954-7. PubMed ID: 18399138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma.
    Conesa-Zamora P; Santaclara V; Gadea-Niñoles E; Ortiz-Reina S; Perez-Guillermo M
    Hum Immunol; 2010 Mar; 71(3):314-7. PubMed ID: 20018222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France.
    Tamalet C; Richet H; Carcopino X; Henry M; Leretraite L; Heid P; Leandri FX; Sancho-Garnier H; Piana L
    J Med Virol; 2010 Aug; 82(8):1431-7. PubMed ID: 20572091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study.
    Tam LS; Chan PK; Ho SC; Yu MM; Yim SF; Cheung TH; Wong MC; Li EK
    J Rheumatol; 2010 Feb; 37(2):330-40. PubMed ID: 20032093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys.
    Vaccarella S; Franceschi S; Snijders PJ; Herrero R; Meijer CJ; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):503-10. PubMed ID: 20142247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.